ACTION OF ERYTHROMYCIN ON "PROTOPLASTS" IN VIVO

Area of Science:

• Microbiology
• Infectious Diseases
• Pharmacology

Background:

• Enterococcal pyelonephritis is a kidney infection caused by Enterococcus bacteria.
• Penicillin is a common antibiotic used to treat bacterial infections, but resistance and persistence can occur.
• Bacterial persistence in alternative forms, like protoplasts, can complicate treatment efficacy.

Purpose of the Study:

• To investigate the persistence of enterococci in protoplast form after penicillin treatment in experimental pyelonephritis.
• To evaluate the in vivo efficacy of erythromycin against these persistent bacterial forms.

Main Methods:

• Induction of experimental enterococcal pyelonephritis in a kidney model.
• Treatment with penicillin to observe bacterial form changes.
• Administration of erythromycin to assess its effect on persistent bacterial forms (protoplasts).

Main Results:

• Penicillin treatment resulted in the persistence of bacteria in protoplast form within the kidneys.
• Erythromycin demonstrated efficacy in killing these bacterial protoplasts in vivo.
• Erythromycin was ineffective against the standard bacterial form of the infection.

Conclusions:

• Intact bacterial cell walls may impede erythromycin's entry and action.
• Erythromycin shows potential for targeting cell-wall-deficient bacteria (protoplasts) in vivo.
• Findings suggest alternative therapeutic strategies may be needed for infections with persistent bacterial forms.